RDH12 and respiratory distress syndrome in premature infants: Debra Thompson (Kellogg Eye Center, Michigan, USA) reminded the group that part of the necessary non-clinical evidence in mouse models was published by her group in 2019 and showed a protection against light damage susceptibility in mice injected with a gene-therapy vector for RDH12-associated IRDs.25